Paul L. Prather
Affiliations: | University of Arkansas for Medical Sciences, United States |
Area:
Pharmacology, Neuroscience BiologyGoogle:
"Paul Prather"Mean distance: 21373.2
Children
Sign in to add trainee| Jennifer Shoemaker | grad student | 2007 | UAMS |
| Kathryn A. Seely | grad student | 2009 | UAMS |
| Maheswari Rajasekaran | grad student | 2011 | UAMS |
| Lisa K. Brents | grad student | 2013 | UAMS |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Janganati V, Salazar P, Parks BJ, et al. (2023) Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats. Frontiers in Pharmacology. 14: 1123261 |
| Cabanlong CV, Russell LN, Fantegrossi WE, et al. (2022) Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors. Toxicological Sciences : An Official Journal of the Society of Toxicology |
| Penthala NR, Shoeib A, Dachavaram SS, et al. (2020) 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands. Bioorganic & Medicinal Chemistry Letters. 30: 127501 |
| Pinson A, Yarbrough AL, Bush JM, et al. (2020) Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity. Pharmacology, Biochemistry, and Behavior. 172949 |
| Jones S, Yarbrough AL, Fantegrossi WE, et al. (2020) Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135). Pharmacology Research & Perspectives. 8: e00561 |
| Ford BM, Cabanlong CV, Tai S, et al. (2019) Reduced tolerance and asymmetrical cross-tolerance to effects of indole quinuclidinone analogue PNR-4-20, a G protein biased CB1R agonist in mice: comparisons with Δ9-THC and JWH-018. The Journal of Pharmacology and Experimental Therapeutics |
| Jones S, Yarbrough AL, Shoeib A, et al. (2019) Enzymatic Analysis of Glucuronidation of Synthetic Cannabinoid 1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22). Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-25 |
| Yarbrough AL, Pinson A, Prather PL, et al. (2019) Oxidative Metabolism and Comparative Analysis of Synthetic Cannabinoid N-(1-adamantyl)-1-(5-fluoropentyl)indazole-3-carboxamide (5F-AKB-48) and the Unfluorinated Analog AKB-48 The Faseb Journal. 33 |
| Yarbrough A, Fujiwara R, Fantegrossi W, et al. (2019) Oxidative metabolism of synthetic cannabinoid STS-135 by recombinant P450S and human liver microsomes Drug Metabolism and Pharmacokinetics. 34: S28 |
| Hutchison RD, Ford BM, Franks LN, et al. (2018) Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ-THC. Frontiers in Pharmacology. 9: 1084 |